Literature DB >> 22251235

Reversible posterior leukoencephalopathy in the course of Goodpasture syndrome.

Abdullah Ozkok1, Omer Celal Elcioglu, Ali Bakan, Kadir Gokhan Atilgan, Sabahat Alisir, Ali Riza Odabas.   

Abstract

Reversible posterior leukoencephalopathy syndrome (RPLS) is characterized by headache, altered consciousness, seizures, and cortical blindness. The most frequent etiological factors are hypertension, kidney diseases, and immunosuppressive drugs such as steroids and cyclophosphamide. Herein we present a case of a 22-year-old female patient presented with alveolar hemorrhage and acute renal failure necessitating hemodialysis. In renal biopsy, necrotizing crescentic glomerulonephritis and immunofluorescence pattern compatible with Goodpasture syndrome were found. Anti-glomerular basement membrane antibody result was positive. At follow-up, respiratory failure ensued, steroid pulse treatment was started, and she was transferred to intensive care unit (ICU). In the ICU, she had visual disturbances and blindness together with seizures. Cranial magnetic resonance imaging (MRI) revealed irregular T2- and fluid-attenuated inversion recovery (FLAIR)-weighted lesions in bilateral occipital lobes. On clinical and radiological grounds, RPLS was diagnosed. With the supportive and anti-hypertensive treatment, RPLS was resolved without a sequela. Subsequent cranial MRI was totally normal. In the literature, RPLS associated with Goodpasture syndrome was reported only once. Hypertension and methylprednisolone might be the responsible etiologies in this case.

Entities:  

Mesh:

Year:  2012        PMID: 22251235     DOI: 10.3109/0886022X.2011.647211

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  4 in total

1.  Anti-glomerular basement membrane disease complicated with posterior reversible encephalopathy syndrome and subcortical cerebral hemorrhage: a case report and review of the literature.

Authors:  Shoji Tsuneyoshi; Shunsuke Yamada; Hidenobu Matsumoto; Sahomi Yamaguchi; Kayo Wakisaka; Kana Ueki; Kiichiro Fujisaki; Tetsuro Ago; Toshiaki Nakano; Takanari Kitazono
Journal:  CEN Case Rep       Date:  2020-04-10

2.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

3.  Posterior reversible encephalopathy syndrome with exercise-induced acute kidney injury in renal hypouricemia type 1.

Authors:  Shuichiro Fujinaga; Akira Ito; Mayu Nakagawa; Tsuneki Watanabe; Yoshiyuki Ohtomo; Toshiaki Shimizu
Journal:  Eur J Pediatr       Date:  2013-03-23       Impact factor: 3.183

4.  Unusual Case of Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-glomerular Basement Membrane Antibody Glomerulonephritis: A Case Report and Review of the Literature.

Authors:  Boram Cha; Dae Young Kim; Hyunil Jang; Seun Deuk Hwang; Huck Jei Choi; Moon-Jae Kim
Journal:  Electrolyte Blood Press       Date:  2017-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.